VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here: IndiaNotes

Filter search : Quote Research All


Companies for search string : Healthcare

Healthcare Global Enterprises Ltd. Healthca.Glo [BSE: NA || NSE: NA ]

Reports for search string : Healthcare

Cyient Q3FY18: Healthy performance; Upside 20%
Rolling over our estimates to FY20E, we maintain our BUY recommendation on the stock with a revised Target Price of Rs700 (from Rs 605 earlier).
Reliance Securities, 19 Jan 2018
Subscribe to Newgen Software Technologies IPO
The co is bringing the issue at p/e multiple of 33 on FY17 eps of Rs 8.26 at higher price band of Rs 240-245/share. Looking after financials of co we recommend “Long Term Subscribe” on it.
Hem Securities, 16 Jan 2018
Newgen Software Technologies IPO: All that you need to know
But if we look into the company’s profitability it is declining, margins are low & Valuation is also not so attractive.Considering these factors, issue seems to be risky therefore we are NUETRAL for t...
Rudra Shares and Stock Brokers, 16 Jan 2018
TCS Q3FY18: Portfolio challenges receding; ADD
TCS 3QFY18 earnings and commentary continues to be constructive as headwinds of the past three years are receding, in-turn leading to rising confidence across verticals.
Equirus Securities, 15 Jan 2018
Upcoming IPOs to watch out for
Initial Public Offering is made public when the company sells its shares first time. The stocks are bought by the public. This way the public become the shareholders in the company.
Guest Author, 09 Jan 2018
Three stocks which can a fetch a return of 20% to 30% in 2018
Virinchi aims to build a niche thought-leadership position in the international markets within the fintech and healthcare domains.Co with strong management team has shown robust financial performance.
Hem Securities, 05 Jan 2018
Derivatives: Buy Adani Port and Cadila Healthcare
Last week, Indian bourses opened on positive note and tested new highs in Tuesdays session. However, from higher levels minor profit booking was seen in mid half of week amid F&O expiry. On Fridays fr...
Way2wealth, 01 Jan 2018
Buy Cadila Healthcare and Sell Ramco Cement
For today’s trade, long position can be initiated at 424-420 for target of Rs 453 with a strict stop loss of Rs 406.
Reliance Securities, 28 Dec 2017
Abbott India: Buy for an upside of 18% over a period of 1 year
Estimating the share price of the company as per P/E valuation P/E of FY19E at 39x , EPS(Est.) at Rs 168.29, the estimated share price for next 1 year tenure turns around to be Rs 6500. We recommend ...
Rudra Shares and Stock Brokers, 26 Dec 2017
Technial Stock Pick: Buy NBCC India and Sell Strides Shasun
The down trend in this stock price (NBCC India Ltd) seems to have completed during this week.After a sharp upmove during mid to later part of Nov, the stock price shifted into gradual declines in the ...
HDFC Sec, 08 Dec 2017
Should you subscribe to Shalby IPO?
Company is bringing the issue at price band of Rs 245-248 /share at p/e multiple of 46-47. Hence, we recommend "Subscribe” on issue for long term.
Hem Securities, 06 Dec 2017
All that you need to know about Future Supply Chain Solutions IPO
Co being one of the largest service providers with an extensive network of facilities in a fast-growing third-party logistics market is looking attractive for long term investment. Hence we recomm...
Hem Securities, 06 Dec 2017
Shalby IPO: All that you need to know
Considering, higher RONW amongst its peers with delivering higher EBITDA & PAT margins, company’s forthcoming expansion plans combined with reduction in debt plans, initiatives to improve operational ...
Rudra Shares and Stock Brokers, 05 Dec 2017
Shalby IPO: Sustainable business model with strong visibility; Subscribe
We believe the Indian hospitals industry is poised to grow in favour of the organised sector with rising affordability, awareness and increasing medical/health insurance penetration. Shalby’s growth p...
Reliance Securities, 05 Dec 2017
Hexaware Tech: Net profit jumps 24.42% in Q3CY17; Overweight
Revenue for the quarter stood at Rs. 9930.71 mn as against Rs. 9041.49 mn when compared with the prior year period, an increase of 9.83%. During Q3 CY17, consolidated net profit jumps to Rs. 1422.59 m...
Firstcall India Equity, 05 Dec 2017
Shalby Hospitals IPO: A good long term investment; Subscribe
The company has showcased healthy EBITDA margins in the range of 20-25% consistently. At the upper price band of INR 248/share, the issue is valued at a PE of 35x with FY17 Adj.EPS of INR 7.0. We reco...
SPA Securities, 05 Dec 2017
Buy AstraZeneca Pharma: A debt free company & 75% promoter stake
Significant technical support and robust Global Pipeline & launches from collaborations offers significant future growth visibility for the company. Also, taking these into consideration, debt free co...
Rudra Shares and Stock Brokers, 30 Nov 2017
HDFC's Technical Switch Trades: Buy Gujarat State Fertilizer & Chemicals and sell Cadila Healthcare
According to HDFC Securities, the stock price GSFC of as per daily timeframe chart seems to have reversed upside of its near term down trend. Meanwhile Cadila Health's negative chart pattern is indica...
HDFC Sec, 23 Nov 2017
Wipro: Things are adding up; retain REDUCE
Growth across top customers continues to be robust and likely reflects the outcomes of the mining initiatives and improving win rates. Top customer revenues grew 25.3% yoy (1Q: 18.5%) while top 2-5 cu...
Equirus Securities, 20 Nov 2017
Granules India Q2FY18: Omnichem JV to ramp-up in rest of fiscal; go Long
Granules India’s (GRAN) 2QFY18 sales/EBITDA/PAT (before JV profits) at 3.93bn/ Rs 769mn/Rs 355mn were largely in line with EE. However, PAT post JV profits (Rs 403mn) was 21% lower on deferred supplie...
Equirus Securities, 20 Nov 2017
View All

Intraday Tips

What are technical calls?
* SEBI certified analyst

View Stock Advice by: